tiprankstipranks
Trending News
More News >
Dr. Reddy's Laboratories Ltd (RDY)
NYSE:RDY
US Market

Dr Reddy's Laboratories (RDY) Financial Statements

Compare
448 Followers

Dr Reddy's Laboratories Financial Overview

Dr Reddy's Laboratories's market cap is currently $11.53B. The company's EPS TTM is $0.196; its P/E ratio is 16.34; and it has a dividend yield of 0.64%. Dr Reddy's Laboratories is scheduled to report earnings on October 24, 2025, and the estimated EPS forecast is $0.16. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue₹ 325.54B₹ 279.16B₹ 245.88B₹ 214.39B₹ 2.56B
Gross Profit₹ 190.43B₹ 163.61B₹ 139.34B₹ 113.84B₹ 1.30B
Operating Income₹ 71.84B₹ 67.73B₹ 57.14B₹ 29.48B₹ 431.44M
EBITDA₹ 96.67B₹ 88.42B₹ 74.43B₹ 45.08B₹ 534.77M
Net Income₹ 56.54B₹ 55.68B₹ 45.07B₹ 23.57B₹ 232.21M
Balance Sheet
Cash & Short-Term Investments₹ 57.91B₹ 81.47B₹ 61.80B₹ 44.37B₹ 472.87M
Total Assets₹ 492.99B₹ 387.52B₹ 321.85B₹ 292.83B₹ 3.63B
Total Debt₹ 46.77B₹ 20.02B₹ 13.47B₹ 33.84B₹ 414.53M
Net Debt₹ 32.11B₹ 12.91B₹ 7.69B₹ 18.99B₹ 211.71M
Total Liabilities₹ 155.82B₹ 106.97B₹ 90.86B₹ 102.30B₹ 1.26B
Stockholders' Equity₹ 333.39B₹ 280.55B₹ 230.99B₹ 190.53B₹ 2.37B
Cash Flow
Free Cash Flow₹ 12.03B₹ 18.00B₹ 40.01B₹ 9.06B₹ 23.14B
Operating Cash Flow₹ 46.43B₹ 45.43B₹ 58.88B₹ 28.11B₹ 35.70B
Investing Cash Flow₹ -58.08B₹ -40.28B₹ -41.37B₹ -26.39B₹ -22.66B
Financing Cash Flow₹ 18.91B₹ -3.76B₹ -26.86B₹ -2.42B₹ -298.00M
Currency in INR

Dr Reddy's Laboratories Earnings and Revenue History

Dr Reddy's Laboratories Debt to Assets

Dr Reddy's Laboratories Cash Flow

Dr Reddy's Laboratories Forecast EPS vs Actual EPS